CompaniesByCap
MTNB
Matinas Biopharma Holdings Inc. (MTNB)
NYSE · Healthcare

Matinas Biopharma Holdings Inc. Cash Flow 2014–2023

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Operating Activities
Operating Cash Flow-7.0M-15.9M-15.3M-19.2M-15.2M-17.4M-14.1M-10.3M-11.5M-6.1M-7.8M
Depreciation & Amort.32,000365,000385,000337,000244,000231,058205,964218,308100,60552,64443,502
Investing Activities
Capital Expenditure218,000892,000260,0005,749405,604535,916942,180076,179
Free Cash Flow-15.5M-20.0M-15.5M-17.4M-14.5M-10.9M-12.4M-6.1M-7.9M
Financing Activities
Dividends Paid
Stock Buybacks

Matinas Biopharma Holdings Inc. Cash Flow — FAQ

Matinas Biopharma Holdings Inc. (MTNB) cash flow over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MTNB's cash flow history?

The chart and table above show Matinas Biopharma Holdings Inc.'s cash flow by year and by quarter, including the growth rate.